Xiang (Silas) Wang
About Xiang (Silas) Wang
Xiang (Silas) Wang is a Senior Director of Small Molecule Drug Substance at Arcus Biosciences, with extensive experience in pharmaceutical development and research. He has held various positions at notable companies including Gilead Sciences, Amgen, and Global Blood Therapeutics, and has contributed to the commercialization of key pharmaceutical products.
Current Role at Arcus Biosciences
Xiang (Silas) Wang serves as the Senior Director of Small Molecule Drug Substance at Arcus Biosciences. He has held this position since 2021, contributing to the development and optimization of small molecule drug candidates. His role involves overseeing the drug substance development process, ensuring that projects align with the company's strategic objectives.
Previous Experience at Gilead Sciences
Prior to his current role, Wang worked at Gilead Sciences as a Senior Research Scientist I from 2011 to 2018. During his seven years at Gilead, he was involved in various research initiatives that supported the development of innovative therapies. His experience at Gilead contributed to his expertise in pharmaceutical research and development.
Background in Chemical Development
Wang has extensive experience in chemical development, having served as the Director of Chemical Development at Global Blood Therapeutics from 2020 to 2021. He also held the position of Associate Director at the same company from 2018 to 2020. His work focused on advancing chemical processes for drug development, enhancing the efficiency and effectiveness of pharmaceutical production.
Education and Expertise
Xiang Wang earned his Bachelor of Science degree in Chemistry from Peking University, where he studied from 1995 to 1999. He then pursued a PhD in Chemistry at Duke University, completing his studies from 1999 to 2004. His educational background provides a solid foundation for his expertise in pharmaceutical process development, evidenced by his contributions to over 20 publications and several industrial patents.
Key Contributions to Pharmaceutical Products
Wang played a significant role in the commercialization of notable pharmaceutical products, including Oxbryta, Epclusa, and Harvoni. His involvement in these projects highlights his expertise in drug development and his ability to contribute to successful product launches in the pharmaceutical industry.